Decreasing viral load pretransplant and passive immunoprophylaxis with hepatitis B immunoglobulin posttransplant prevents hepatitis B virus recurrence after liver transplantation: an 8-year single-center experience.
McGill University Health Center, Montreal, Quebec, Canada.
J I
JI
Tchervenkov
P
P
Metrakos
M
M
Deschenes
E
E
Alpert
A J
AJ
Tector
M
M
Cantarovich
J S
JS
Barkun
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control* / Q000821:virology; D006510:Hepatitis B Antibodies / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D016031:Liver Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D055502:Secondary Prevention; D015996:Survival Rate; D019562:Viral Load
D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D016898:Interferon-alpha; D019259:Lamivudine